Wikidata

(Q57949352)

English

Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma

scientific article published on 27 February 2008

In more languages
default for all languages
No label defined

No description defined

Statements

title
Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18301889
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18301889%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q57949352&oldid=2213693569"